| Literature DB >> 35261950 |
Ryota Mori1, Takayuki Ogino1,2, Yuki Sekido1, Tsuyoshi Hata1, Hidekazu Takahashi1, Norikatsu Miyoshi1, Mamoru Uemura1, Yuichiro Doki1, Hidetoshi Eguchi1, Tsunekazu Mizushima1,2,3.
Abstract
Background: Stoma outlet obstruction (SOO) is much more common after total proctocolectomy (TPC) and ileal-pouch anal anastomosis (IPAA) for ulcerative colitis (UC) compared to after rectal surgery for cancer. Few prior reports have evaluated anatomical risk factors for SOO. In this study we aimed to clarify the risk factors for SOO after IPAA, focusing on the anatomical perspective.Entities:
Keywords: ileal pouch‐anal anastomosis; small bowel obstruction; stoma outlet obstruction; total proctocolectomy; ulcerative colitis
Year: 2021 PMID: 35261950 PMCID: PMC8889852 DOI: 10.1002/ags3.12512
Source DB: PubMed Journal: Ann Gastroenterol Surg ISSN: 2475-0328
FIGURE 1Methods of measuring the distance between the root of the superior mesenteric artery and the bottom of the external anal sphincter (rSMA‐bEAS) on CT images. a: Axial image showing the location of the root of the superior mesenteric artery (rSMA). b: Axial image showing the location of the bottom of the external anal sphincter (bEAS). c: Sagittal image showing the fixed angle such that rSMA and bEAS are on the same slice
FIGURE 2Methods of measuring the abdominal cavity depth and abdominal wall thickness at the site of stoma construction. a: In a case with a diverting ileostomy in the umbilicus. b: In a case with a diverting ileostomy in the lower abdomen
FIGURE 3Representative CT images of stoma outlet obstruction (SOO). The arrow points to the area where the intestine was obstructed at the site of a diverting ileostomy. a: Axial image. b: Sagittal image
Clinical characteristics of participants
| n = 68 | |
|---|---|
| Sex | |
| Male | 45 (66.2%) |
| Female | 23 (33.8%) |
| Age at surgery, y | 49.0 ± 16.5 |
| Disease duration, y | 9 ± 9.7 |
| Body mass index, kg/m2 | 20.8 ± 4.3 |
| Height, m | 165.1 ± 9.3 |
| Body weight, kg | 57.5 ± 14.2 |
| Smoking | 12 (17.6%) |
| Type 2 diabetes | 5 (7.4%) |
| Extent of colitis | |
| Pancolitis | 57 (83.8%) |
| Left‐sided colitis | 10 (14.7%) |
| Proctitis | 0 (0.0%) |
| Others | 1 (1.5%) |
| Surgical indication | |
| Cancer/Dysplasia | 27 (39.7%) |
| Severe/Fulminant | 19 (27.9%) |
| Refractory | 22 (32.4%) |
| Nutritional status (Onodera PNI) | |
| >40 | 27 (39.7%) |
| ≦40 | 41 (60.3%) |
| Preoperative CRP (mg/dL) | 0.5 ± 3.5 |
| Preoperative medication | |
| Amino salicylate | 55 (80.9%) |
| Anti‐TNFα antibody | 26 (38.2%) |
| Steroid | 46 (67.6%) |
| Immunosuppressant | 33 (48.5%) |
Data are presented as n (%) or median ± SD.
Abbreviations: CRP, C‐reactive protein; PNI, prognostic nutritional index; TNF, tumor necrosis factor.
Comparison of clinical characteristics between SOO group and non‐SOO group
| SOO group (n = 18) | Non‐SOO group (n = 50) |
| |
|---|---|---|---|
| Sex | .003 | ||
| Male | 17 (94.4%) | 28 (56.0%) | |
| Female | 1 (5.6%) | 22 (44.0%) | |
| Age at surgery, y | 59.0 ± 21.4 | 48.5 ± 14.6 | .4 |
| Disease duration, y | 5.5 ± 7.6 | 11.0 ± 14.6 | .1 |
| Body mass index, kg/m2 | 20.8 ± 3.6 | 20.8 ± 4.6 | .9 |
| Height, cm | 169.2 ± 7.2 | 162.0 ± 9.8 | .09 |
| Body weight, kg | 60.1 ± 10.8 | 56.5 ± 15.3 | .53 |
| Smoking | 3 (16.7%) | 9 (18.0%) | .76 |
| Type 2 diabetes | 1 (5.6%) | 4 (8.0%) | .65 |
| Extent of colitis | .95 | ||
| Pancolitis | 15 (83.3%) | 42 (84.0%) | |
| Left‐sided colitis/Others | 3 (16.7%) | 8 (16.0%) | |
| Surgical indication | .43 | ||
| Cancer/Dysplasia | 7 (38.9%) | 20 (40.0%) | |
| Severe/Fulminant | 3 (16.7%) | 16 (32.0%) | |
| Refractory | 8 (44.4%) | 14 (28.0%) | |
| Nutritional status (Onodera PNI) | .93 | ||
| >40 | 7 (38.9%) | 20 (40.0%) | |
| ≦40 | 11 (61.1%) | 30 (60.0%) | |
| Preoperative CRP (mg/dL) | 0.5 ± 3.3 | 0.5 ± 3.5 | .91 |
| Preoperative medication | |||
| Amino salicylate | 15 (83.3%) | 40 (80.0%) | .76 |
| Anti‐TNFα antibody | 10 (55.6%) | 16 (32.0%) | .08 |
| Steroid | 11 (61.1%) | 35 (70.0%) | .68 |
| Immunosuppressant | 12 (66.7%) | 21 (42.0%) | .07 |
Data are presented as n (%) or median ± SD.
Abbreviations: CRP, C‐reactive protein; PNI, prognostic nutritional index; SOO, stoma outlet obstruction; TNF, tumor necrosis factor.
Comparison of surgery‐related and postoperative factors between SOO group and non‐SOO group
| SOO group (n = 18) | Non‐SOO group (n = 50) |
| |
|---|---|---|---|
|
| |||
| Operation time, min | 385.5 ± 158.7 | 368.0 ± 179.4 | .23 |
| Blood loss (mL) | 235.0 ± 979.7 | 179.4 ± 315.4 | .86 |
| Surgical approach | .95 | ||
| Open | 1 (5.6%) | 3 (6.0%) | |
| Laparoscopy | 17 (94.4%) | 47 (94.0%) | |
| Anastomosis (IPAA) | .69 | ||
| Hand‐sewn | 8 (44.4%) | 25 (50.0%) | |
| Stapled | 10 (55.6%) | 25 (50.0%) | |
| Strategy | .01 | ||
| 2‐stage surgery (TPC) | 17 (94.4%) | 32 (64.0%) | |
| 3‐stage surgery (STC + RR) | 1 (5.6%) | 18 (36.0%) | |
| Site of stoma construction | .23 | ||
| Umbilicus | 13 (72.2%) | 28 (56.0%) | |
| Right lower abdomen | 5 (27.8%) | 22 (44.0%) | |
|
| |||
| Intra‐abdominal abscess | 2 (11.1%) | 1 (2.0%) | .11 |
| High‐output syndrome | 14 (77.8%) | 17 (34.0%) | .002 |
Data are presented as n (%) or median ± SD.
IPAA, ileal pouch‐anal anastomosis; RR, residual rectal resection; SOO, stoma outlet obstruction; STC, subtotal proctocolectomy; TPC, total proctocolectomy.
aHigh‐output syndrome: stoma drainage of 2000 mL/d for more than 2 d or 1500 mL/d for more than 3 d.
Comparison of anatomical factors between SOO group and non‐SOO group
| SOO group (n = 18) | Non‐SOO group (n = 50) |
| |
|---|---|---|---|
| Thickness of abdominal wall (mm) | 18.3 ± 11.7 | 23.4 ± 9.2 | .28 |
| Depth of the abdominal cavity (mm) | 66.0 ± 17.8 | 62.2 ± 24.1 | .73 |
| rSMA‐bEAS (mm) | 322.2 ± 22.0 | 294.0 ± 22.1 | .001 |
| Height adjusted rSMA‐bEAS (mm/m) | 191.8 ± 9.0 | 180.5 ± 10.7 | .002 |
Data are presented as median ± SD.
Abbreviations: bEAS, bottom of the external anal sphincter; rSMA, the root of superior mesenteric artery; SOO, stoma outlet obstruction.
Univariate and multivariate association with SOO
| SOO group (n = 18) | Non‐SOO group (n = 50) | Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|---|---|
|
| Odds ratio (95% CI) |
| Odds ratio (95% CI) | |||
| Sex | 0.003 | 13.4 | 0.01 | 25.9 | ||
| Male | 17 (94.4%) | 28 (56.0%) | (1.6–108.3) | (2.1–318.5) | ||
| Female | 1 (5.6%) | 22 (44.0%) | ||||
| Strategy | 0.01 | 9.6 | 0.09 | 9.1 | ||
| 2‐stage procedure (TPC) | 17 (94.4%) | 32 (64.0%) | (1.2–77.9) | (0.7–114.8) | ||
| 3‐stage procedure (STC + RR) | 1 (5.6%) | 18 (36.0%) | ||||
| High‐output syndrome | 0.002 | 6.8 | 0.17 | 2.9 | ||
| Yes | 14 (77.8%) | 17 (34.0%) | (1.9–23.9) | (0.6–13.5) | ||
| No | 4 (22.2%) | 33 (66.0%) | ||||
| Adjusted rSMA‐bEAS, mm/m | 0.001 | 6.3 | 0.004 | 13.1 | ||
| >191.0 | 11 (61.1%) | 10 (20.0%) | (1.9–20.3) | (2.3–73.7) | ||
| ≤191.0 | 7 (38.9%) | 40 (80.0%) | ||||
Data are presented as n (%).
bEAS, bottom of the external anal sphincter; RR, residual rectal resection; rSMA, root of superior mesenteric artery; SOO, stoma outlet obstruction; STC, subtotal proctocolectomy; TPC, total proctocolectomy.